Generation Wellness to a Global Audience with Multilingual, Accessible AI Solutions MESA, ARIZONA / ACCESS Newswire / November 3, 2025 / Medical Care Technologies, Inc. (OTC Pink:MDCE) is excited to ...
Dr. Naderi reveals how younger generations are embracing prejuvenation with collagen-boosting treatments and skincare to maintain a natural, youthful glow before aging signs appear. RESTON, VA / ...
LUND, SE / ACCESS Newswire / November 3, 2025 / BioInvent International AB ("BioInvent")(STO:BINV)(Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first ...
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and update SOUTH SAN FRANCISCO, CA / ACCESS Newswire / ...
The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first monthThe Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, ...
LUND, SE / ACCESS Newswire / November 3, 2025 / BioInvent International AB ("BioInvent") (STO:BINV)(Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and ...
Company Extending Warranty as a Promise of Quality and a Thank You to Customers. SALT LAKE CITY, UTAH / ACCESS Newswire / November 3, 2025 / To show Hoggan Scientific's ongoing commitment to customer ...
LUND, SWEDEN / ACCESS Newswire / November 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, ...
Operators highlight practical levers to speed AI, interoperability, and cyber resilience SAN ANTONIO, TX / ACCESS Newswire / November 3, 2025 / Black Book™ today released results from a flash survey ...
UPPSALA, SWEDEN / ACCESS Newswire / November 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - A Nomination Committee consisting of shareholder representatives has been established for Senzime AB (publ.) in ...
Biohope Announces Collaboration to Advance Immunobiogram Diagnostic Solution to Optimize Immunosuppression Therapy for Transplant Patients MADRID, ES / ACCESS Newswire / November 3, 2025 / Biohope, a ...
Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch ...